Bausch + Lomb reported an adjusted Ebitda of $170 million in the first quarter of 2022, down from $198 million the year earlier, as growth in organic revenues was more than offset by foreign currency headwinds and the negative impact from new Covid-19 lockdowns in China. For the full year, ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.